News > FDA Approval Of Third Vaccine Dose For Kidney Transplant Patients

FDA Approval Of Third Vaccine Dose For Kidney Transplant Patients

The American Association of Kidney Patients (AAKP) thanks the U.S. Food and Drug Administration (FDA) for incorporating the unique insights of America's kidney transplant recipients and the medical professionals who care for them in their authorization of a third vaccine dose. 

Kidney transplant patients dutifully fulfilled their societal responsibility to get vaccinated, yet as science has demonstrated, initial vaccines generated few or no antibodies or protections.